• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎相关神经系统并发症:发病机制与治疗。

Neurological Complications of COVID-19: Underlying Mechanisms and Management.

机构信息

Department of Neurology and Psychiatry, Assiut University Hospitals, Assiut 71511, Egypt.

Department of Physiology and Pharmacology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA.

出版信息

Int J Mol Sci. 2021 Apr 15;22(8):4081. doi: 10.3390/ijms22084081.

DOI:10.3390/ijms22084081
PMID:33920904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8071289/
Abstract

COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss of taste and smell, encephalitis, encephalopathy, and cerebrovascular diseases are the most common neurological complications that are associated with COVID-19. In addition, seizures, neuromuscular junctions' disorders, and Guillain-Barré syndrome were reported as complications of COVID-19, as well as neurodegenerative and demyelinating disorders. However, the management of these conditions remains a challenge. In this review, we discuss the prevalence, pathogenesis, and mechanisms of these neurological sequelae that are secondary to SARS-CoV-2 infection. We aim to update neurologists and healthcare workers on the possible neurological complications associated with COVID-19 and the management of these disease conditions.

摘要

新型冠状病毒肺炎(COVID-19)是由新型人类冠状病毒(HCoV)严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的严重呼吸系统疾病。该病毒于 2019 年 12 月被发现,由于病例数量众多,世界卫生组织(WHO)于 2020 年 3 月宣布该疾病为全球大流行。尽管 SARS-CoV-2 主要影响呼吸系统,但几项研究报告称 COVID-19 患者存在神经系统并发症。头痛、头晕、味觉和嗅觉丧失、脑炎、脑病和脑血管疾病是与 COVID-19 相关的最常见神经系统并发症。此外,还报告了 COVID-19 的并发症包括癫痫发作、神经肌肉接头疾病和格林-巴利综合征,以及神经退行性和脱髓鞘疾病。然而,这些疾病的管理仍然是一个挑战。在这篇综述中,我们讨论了继发于 SARS-CoV-2 感染的这些神经系统后遗症的流行率、发病机制和机制。我们旨在让神经科医生和医疗保健工作者了解 COVID-19 可能引起的神经系统并发症,以及这些疾病的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ce/8071289/821e065ce492/ijms-22-04081-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ce/8071289/9d3c2f8e2bfc/ijms-22-04081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ce/8071289/821e065ce492/ijms-22-04081-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ce/8071289/9d3c2f8e2bfc/ijms-22-04081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ce/8071289/821e065ce492/ijms-22-04081-g002.jpg

相似文献

1
Neurological Complications of COVID-19: Underlying Mechanisms and Management.新型冠状病毒肺炎相关神经系统并发症:发病机制与治疗。
Int J Mol Sci. 2021 Apr 15;22(8):4081. doi: 10.3390/ijms22084081.
2
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.与严重急性呼吸综合征冠状病毒2型及其他冠状病毒相关的神经学表现:给临床医生的一篇叙述性综述
Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16.
3
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.新型冠状病毒(CoV)在神经系统中的发病机制和新兴病原体 SARS-CoV-2 的证据:神经系统损伤和表现的综述。
J Mol Neurosci. 2021 Nov;71(11):2192-2209. doi: 10.1007/s12031-020-01767-6. Epub 2021 Jan 19.
4
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.COVID-19 大流行对神经系统和神经精神的影响。
Can J Neurol Sci. 2021 Jan;48(1):9-24. doi: 10.1017/cjn.2020.173. Epub 2020 Aug 5.
5
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 冠状病毒病(COVID-19)相关的神经症状、表现和并发症。
J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23.
6
Neurological Sequelae of COVID-19.新型冠状病毒肺炎的神经系统后遗症。
J Integr Neurosci. 2022 Apr 6;21(3):77. doi: 10.31083/j.jin2103077.
7
A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.新型冠状病毒感染患者的神经病变综述。
Med Sci Monit. 2021 Jun 19;27:e932962. doi: 10.12659/MSM.932962.
8
COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.COVID-19 与神经系统表现:来自儿童神经科医生视角的综合分析。
World J Pediatr. 2022 Jun;18(6):373-382. doi: 10.1007/s12519-022-00550-4. Epub 2022 Apr 27.
9
COVID-19 and Neurology: An Emerging Association.新型冠状病毒肺炎与神经科:新兴关联
Infect Disord Drug Targets. 2021;21(8):e160921191570. doi: 10.2174/1871526521666210218202226.
10
SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.严重急性呼吸综合征冠状病毒2感染与吉兰-巴雷综合征:潜在致病机制综述
Front Immunol. 2021 May 10;12:674922. doi: 10.3389/fimmu.2021.674922. eCollection 2021.

引用本文的文献

1
Cerebrospinal Fluid Proteomic Profiling Reveals Proteins Associated with Neuroinflammatory Response in COVID-19 Patients.脑脊液蛋白质组分析揭示了与新冠肺炎患者神经炎症反应相关的蛋白质。
ACS Omega. 2025 Jun 11;10(24):25489-25497. doi: 10.1021/acsomega.5c00707. eCollection 2025 Jun 24.
2
NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse model.N-甲基-D-天冬氨酸(NMDA)受体拮抗剂可减轻新型冠状病毒肺炎(COVID-19)诱导的神经炎症,并提高小鼠模型的存活率。
Sci Rep. 2025 Jun 4;15(1):19603. doi: 10.1038/s41598-025-00738-4.
3
Guillain-Barré syndrome (GBS) after severe/critical COVID-19 or COVID-19 vaccination.

本文引用的文献

1
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.重新定位 HIV 蛋白酶抑制剂和核苷(酸)RNA 聚合酶抑制剂以治疗 SARS-CoV-2 感染和 COVID-19。
Eur J Clin Pharmacol. 2021 Sep;77(9):1297-1307. doi: 10.1007/s00228-021-03108-x. Epub 2021 Mar 4.
2
Clinical utility of serial systemic immune inflammation indices (SSIIi) in the context of post covid-19 neurological syndrome (PCNS).新冠后神经综合征(PCNS)背景下连续系统性免疫炎症指标(SSIIi)的临床应用价值
J Neurol Sci. 2021 Apr 15;423:117356. doi: 10.1016/j.jns.2021.117356. Epub 2021 Feb 20.
3
重症/危重症新型冠状病毒肺炎(COVID-19)或COVID-19疫苗接种后发生的吉兰-巴雷综合征(GBS)
Eur J Med Res. 2025 Feb 24;30(1):131. doi: 10.1186/s40001-025-02378-w.
4
Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis.2019冠状病毒病大流行期间的面神经麻痹:一项汇总分析
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251315057. doi: 10.1177/19160216251315057.
5
Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data.基础疾病及并发症对韩国新冠疫情死亡率的影响:基于国民健康保险服务数据的分析
Arch Public Health. 2025 Jan 23;83(1):20. doi: 10.1186/s13690-025-01509-3.
6
Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies.新型冠状病毒 2 型的神经精神负担:对其病理生理学、潜在机制及管理策略的综述
Viruses. 2024 Nov 21;16(12):1811. doi: 10.3390/v16121811.
7
mC RNA methylation: a potential mechanism for infectious Alzheimer's disease.mRNA甲基化:感染性阿尔茨海默病的一种潜在机制。
Front Cell Dev Biol. 2024 Aug 8;12:1440143. doi: 10.3389/fcell.2024.1440143. eCollection 2024.
8
Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.共病与长新冠之间的相互作用:挑战和多学科方法。
Biomolecules. 2024 Jul 11;14(7):835. doi: 10.3390/biom14070835.
9
A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management.关于探索新冠病毒神经领域的全面综述:病因发病机制及临床管理见解
Cureus. 2024 May 11;16(5):e60079. doi: 10.7759/cureus.60079. eCollection 2024 May.
10
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development.我们在新冠疫情时代过去四年充满挑战的岁月中学到的经验教训:药物治疗、新冠长期并发症和疫苗研发。
Virol J. 2024 Apr 26;21(1):98. doi: 10.1186/s12985-024-02370-6.
Toxicity of psychotropic drugs in patients with COVID-19: A systematic review.
精神药物在 COVID-19 患者中的毒性:一项系统评价。
Gen Hosp Psychiatry. 2021 May-Jun;70:1-9. doi: 10.1016/j.genhosppsych.2021.02.006. Epub 2021 Feb 18.
4
Peripheral Nervous System Manifestations Associated with COVID-19.与 COVID-19 相关的周围神经系统表现。
Curr Neurol Neurosci Rep. 2021 Feb 14;21(3):9. doi: 10.1007/s11910-021-01102-5.
5
COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review.新冠病毒疾病的病理生理学表明,缺血性中风的发生是意料之中的,并非个别现象——一项系统综述
Front Neurol. 2021 Jan 28;11:607221. doi: 10.3389/fneur.2020.607221. eCollection 2020.
6
COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review.COVID-19 与中枢神经系统脱髓鞘疾病患者的疾病修正治疗:系统评价。
Mult Scler Relat Disord. 2021 May;50:102800. doi: 10.1016/j.msard.2021.102800. Epub 2021 Jan 29.
7
Rituximab in Myasthenia Gravis - Where do we stand?利妥昔单抗治疗重症肌无力:现状如何?
Expert Opin Biol Ther. 2021 Aug;21(8):1013-1023. doi: 10.1080/14712598.2021.1889509. Epub 2021 Apr 2.
8
COVID-19 and long-term neurological problems: Challenges ahead with Post-COVID-19 Neurological Syndrome.COVID-19 与长期神经系统问题:后 COVID-19 神经系统综合征面临的挑战。
Aust J Gen Pract. 2021 Jan 12;50. doi: 10.31128/AJGP-COVID-43.
9
Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19.新型冠状病毒肺炎(COVID-19)的多发性硬化症(MS)患者和非MS患者脉络丛中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)转录本的存在情况
Neurol Neuroimmunol Neuroinflamm. 2021 Jan 27;8(2). doi: 10.1212/NXI.0000000000000957. Print 2021 Mar 4.
10
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 冠状病毒病(COVID-19)相关的神经症状、表现和并发症。
J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23.